Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,595,444
+$3,641,593 QoQ
Shares Held
182,462
+11.7% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
2.81%
of 13F equity value
Holder Rank
#92
of 1,603 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Parkwood LLC holds $40,884,526 across 2 Drug Manufacturers - General names. NVS ranks #1 (69.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
This page
|
182,462 | $28,595,444 | |
| 2 | AZN |
Astrazeneca PLC
|
64,809 | $12,289,082 |
All Filings in NVS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,595,444 | 182,462 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $24,953,851 | 163,364 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $20,302,736 | 147,260 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,051,559 | 132,966 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $27,505,572 | 227,300 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,858,907 | 106,377 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,481,704 | 117,991 | Shares | Sole | 2025-02-14 | |
| 2020-09-30 | $5,137,422 | 59,078 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,028,338 | 57,572 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $10,068,546 | 122,117 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||